FRANKLIN MARTIN E
SC 13D/A, 2000-04-06
Previous: EXELIXIS INC, 8-A12G, 2000-04-06
Next: FRANKLIN MARTIN E, 4, 2000-04-06



<PAGE>

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                  SCHEDULE 13D
                                (AMENDMENT NO.1)

                    Under the Securities Exchange Act of 1934

                             SPECIALTY CATALOG CORP.
- --------------------------------------------------------------------------------
                                (Name of Issuer)

                     Common Stock, par value $0.01 per share
- --------------------------------------------------------------------------------
                         (Title of Class of Securities)

                                   84748Q-10-3
- --------------------------------------------------------------------------------
                                 (CUSIP Number)

                            Jeffrey S. Tullman, Esq.
                           1350 Avenue of the Americas
                            New York, New York 10019
                                 (212) 541-6222
- --------------------------------------------------------------------------------
           (Name, Address and Telephone Number of Person Authorized to
                      Receive Notices and Communications)

                                 March 30, 2000
- --------------------------------------------------------------------------------
             (Date of Event which requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of (Section) 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check
the following box [ ].

*The remainder of this cover page shall be filed out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).

<PAGE>

                                  SCHEDULE 13D

- ---------------------                                          -----------------
CUSIP NO. 84748Q-10-3                                          Page 2 of 5 Pages
- ---------------------                                          -----------------

- --------------------------------------------------------------------------------
         NAME OF REPORTING PERSON
         S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

1        MARTIN E. FRANKLIN
- --------------------------------------------------------------------------------
         CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*               (a) [ ]
2        NOT APPLICABLE                                                  (b) [ ]
- --------------------------------------------------------------------------------

3        SEC USE ONLY
- --------------------------------------------------------------------------------
         SOURCE OF FUNDS*

4        PF
- --------------------------------------------------------------------------------

5        CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
         PURSUANT TO ITEMS 2(d) or 2(E)                                      [ ]
- --------------------------------------------------------------------------------
         CITIZENSHIP OR PLACE OF ORGANIZATION

6        United Kingdom
- --------------------------------------------------------------------------------
                               SOLE VOTING POWER

                        7      336,754
  NUMBER OF             --------------------------------------------------------
   SHARES                      SHARED VOTING POWER
BENEFICIALLY
  OWNED BY              8      0
    EACH                --------------------------------------------------------
  REPORTING                    SOLE DISPOSITIVE POWER
   PERSON
    WITH                9      336,754
                        --------------------------------------------------------
                               SHARED DISPOSITIVE POWER

                        10     0
- --------------------------------------------------------------------------------
         AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

11       336,754
- --------------------------------------------------------------------------------
12       CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
         CERTAIN SHARES*                                                     [ ]
- --------------------------------------------------------------------------------
         PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

13       7.7%
- --------------------------------------------------------------------------------
         TYPE OF REPORTING PERSON*

14       IN
- --------------------------------------------------------------------------------

                      *SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>

Information contained in this statement on Schedule 13D is as of the date
hereof, unless otherwise expressly provided herein.

Item 1.  Security and Issuer.

    (i)    Name and Issuer: Specialty Catalog Corp.

    (ii)   Address of the Principal Executive Offices of Issuer: 31 Bristol
           Drive, South Easton, MA 02375.

    (iii)  Title of Class of Equity Securities to which this Statement relates:
           Common Stock, $0.01 par value (the "Common Stock").

Item 2.  Identity and Background.

    (a-c)  This statement is being filed on behalf of Martin E. Franklin (the
           "Reporting Person"). Mr. Franklin's principal employment is as
           Chairman and Chief Executive Officer of Marlin Holdings, Inc. The
           business address and principal office of the Reporting Person is 555
           Theodore Fremd Avenue, Rye, New York 10580.

    (d)(e) During the last five years, the Reporting Person (i) has not been
           convicted in a criminal proceeding (excluding traffic violations or
           similar misdemeanors) and (ii) has not been a party to a civil
           proceeding of a judicial or administrative body of competent
           jurisdiction and as a result of such proceeding was or is subject to
           a judgment, decree or final order enjoining future violations of, or
           prohibiting or mandating activities subject to, federal or state
           securities laws or finding any violation with respect to such laws.

    (f)    Mr. Franklin is a citizen of the United Kingdom.

Item 3.  Source and Amount of Funds or Other Consideration.

    Mr. Franklin acquired 105,000 shares in open market purchases at $3 per
share on March 30, 2000 for a total purchase price of $315,000. Mr. Franklin
used his personal funds to acquire the Common Stock.

Item 4.  Purpose of Transaction.

The Shares have been acquired by the Reporting Person for investment purposes
only. The Reporting Person expects to evaluate on an ongoing basis the Company's
financial condition, business operations and prospects, the status of any
business combination involving the Company, the market price of the Shares,
conditions in the securities markets generally, general economic and industry
conditions and other factors. The Reporting Person may at any time and from time
to time acquire additional Shares. The Reporting Person has no plans to effect
any of the transactions required to be described in Item 4 of Schedule 13D.

<PAGE>

Item 5.  Interest in Securities of the Issuer.

    (a)(b) Mr. Franklin beneficially owns an aggregate of 333,188 shares of the
           Company's Common Stock and holds 3,566 options to buy Common Stock
           currently exercisable, or 7.7% based on 4,351,386 shares of Common
           Stock outstanding as disclosed in the Company's Form 10-Q for the
           quarter ended October 2, 1999 as filed with the Securities and
           Exchange Commission. Mr. Franklin is a director of the Company. Mr.
           Franklin has the sole power to vote and the sole power to dispose of
           the 333,188 shares of Common Stock and 3,566 options he beneficially
           owns.

    (c)    None.

    (d)    None.

    (e)    Not applicable.

Item 6. Contracts, Arrangements, Understandings or Relationships with respect to
Securities of the Issuer.

    Note that the transactions previously reported on Schedule 13D of Specialty
Catalog Corp., dated December 2, 1999, described in Items 4 and 6 thereof, have
been terminated and sole voting power has been restored to Mr. Franklin's shares
of Company Common Stock.

    On January 2, 1998, Mr. Franklin was granted 2,667 options to purchase
Common Stock pursuant to the Specialty Catalog Corp. 1996 Stock Incentive Plan,
as amended, 20% of which become exercisable on and after each of the first five
(5) anniversaries of the date of the grant. Presently, 1,601 options remain
unvested.

<PAGE>

                                    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.


Date: April 5, 2000
                                            /s/ Martin E. Franklin
                                            ------------------------------------
                                            Martin E. Franklin



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission